NEW AGONIST FOR THERAPY OF DISORDER RELATED TO DAMAGED NEUROTRANSMISSION

PROBLEM TO BE SOLVED: To provide a nutritional supplementary food, a food and a livestock feed or a pharmaceutical composition, for therapy of disorders related to damaged neurotransmission in an animal including a human.SOLUTION: An oregano extract and a volatile component thereof are used. A nutri...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: FOWLER ANN, CLAUS KILPERT, GOEDE SCHUELER, REGINA GORALCZYK
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator FOWLER ANN
CLAUS KILPERT
GOEDE SCHUELER
REGINA GORALCZYK
description PROBLEM TO BE SOLVED: To provide a nutritional supplementary food, a food and a livestock feed or a pharmaceutical composition, for therapy of disorders related to damaged neurotransmission in an animal including a human.SOLUTION: An oregano extract and a volatile component thereof are used. A nutritional supplementary food, a food and a livestock feed or a pharmaceutical composition contain such an extract or a volatile component thereof. The oregano extract is extracted from all or some of a plant belonging to Origanum such as origanum vulgare and Thymus such as thymus vulgaris. An extraction method is solvent, NO, supercritical COor steam distillation, or the like. The oregano extract is a serotonin reuptake inhibitor, a noradrenaline reuptake inhibitor and a dopamine reuptake inhibitor, and serves as an antidepressant drug, a mood improving agent, a stress emollient, a symptom improving agent, an anxiety reducing agent, an obsessional behavior reducing agent and the like. The administration target includes animals such as domestic animal and pet, fishes, and the like.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_JP2014122215A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>JP2014122215A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_JP2014122215A3</originalsourceid><addsrcrecordid>eNrjZPDwcw1XcHT39_MMDlFw8w9SCPFwDXIMiFTwd1Nw8Qz2D3JxDVIIcvVxDHF1UQjxV3Bx9HV0BzL9XEOD_EOCHP2CfT2Dgz39_XgYWNMSc4pTeaE0N4OSm2uIs4duakF-fGpxQWJyal5qSbxXgJGBoYmhkZGRoamjMVGKAGSlLVk</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>NEW AGONIST FOR THERAPY OF DISORDER RELATED TO DAMAGED NEUROTRANSMISSION</title><source>esp@cenet</source><creator>FOWLER ANN ; CLAUS KILPERT ; GOEDE SCHUELER ; REGINA GORALCZYK</creator><creatorcontrib>FOWLER ANN ; CLAUS KILPERT ; GOEDE SCHUELER ; REGINA GORALCZYK</creatorcontrib><description>PROBLEM TO BE SOLVED: To provide a nutritional supplementary food, a food and a livestock feed or a pharmaceutical composition, for therapy of disorders related to damaged neurotransmission in an animal including a human.SOLUTION: An oregano extract and a volatile component thereof are used. A nutritional supplementary food, a food and a livestock feed or a pharmaceutical composition contain such an extract or a volatile component thereof. The oregano extract is extracted from all or some of a plant belonging to Origanum such as origanum vulgare and Thymus such as thymus vulgaris. An extraction method is solvent, NO, supercritical COor steam distillation, or the like. The oregano extract is a serotonin reuptake inhibitor, a noradrenaline reuptake inhibitor and a dopamine reuptake inhibitor, and serves as an antidepressant drug, a mood improving agent, a stress emollient, a symptom improving agent, an anxiety reducing agent, an obsessional behavior reducing agent and the like. The administration target includes animals such as domestic animal and pet, fishes, and the like.</description><language>eng</language><subject>FOODS OR FOODSTUFFS ; FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BYSUBCLASSES A23B - A23J ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OFNUTRITIVE QUALITIES, PHYSICAL TREATMENT ; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES</subject><creationdate>2014</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20140703&amp;DB=EPODOC&amp;CC=JP&amp;NR=2014122215A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20140703&amp;DB=EPODOC&amp;CC=JP&amp;NR=2014122215A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>FOWLER ANN</creatorcontrib><creatorcontrib>CLAUS KILPERT</creatorcontrib><creatorcontrib>GOEDE SCHUELER</creatorcontrib><creatorcontrib>REGINA GORALCZYK</creatorcontrib><title>NEW AGONIST FOR THERAPY OF DISORDER RELATED TO DAMAGED NEUROTRANSMISSION</title><description>PROBLEM TO BE SOLVED: To provide a nutritional supplementary food, a food and a livestock feed or a pharmaceutical composition, for therapy of disorders related to damaged neurotransmission in an animal including a human.SOLUTION: An oregano extract and a volatile component thereof are used. A nutritional supplementary food, a food and a livestock feed or a pharmaceutical composition contain such an extract or a volatile component thereof. The oregano extract is extracted from all or some of a plant belonging to Origanum such as origanum vulgare and Thymus such as thymus vulgaris. An extraction method is solvent, NO, supercritical COor steam distillation, or the like. The oregano extract is a serotonin reuptake inhibitor, a noradrenaline reuptake inhibitor and a dopamine reuptake inhibitor, and serves as an antidepressant drug, a mood improving agent, a stress emollient, a symptom improving agent, an anxiety reducing agent, an obsessional behavior reducing agent and the like. The administration target includes animals such as domestic animal and pet, fishes, and the like.</description><subject>FOODS OR FOODSTUFFS</subject><subject>FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BYSUBCLASSES A23B - A23J</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OFNUTRITIVE QUALITIES, PHYSICAL TREATMENT</subject><subject>THEIR TREATMENT, NOT COVERED BY OTHER CLASSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2014</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZPDwcw1XcHT39_MMDlFw8w9SCPFwDXIMiFTwd1Nw8Qz2D3JxDVIIcvVxDHF1UQjxV3Bx9HV0BzL9XEOD_EOCHP2CfT2Dgz39_XgYWNMSc4pTeaE0N4OSm2uIs4duakF-fGpxQWJyal5qSbxXgJGBoYmhkZGRoamjMVGKAGSlLVk</recordid><startdate>20140703</startdate><enddate>20140703</enddate><creator>FOWLER ANN</creator><creator>CLAUS KILPERT</creator><creator>GOEDE SCHUELER</creator><creator>REGINA GORALCZYK</creator><scope>EVB</scope></search><sort><creationdate>20140703</creationdate><title>NEW AGONIST FOR THERAPY OF DISORDER RELATED TO DAMAGED NEUROTRANSMISSION</title><author>FOWLER ANN ; CLAUS KILPERT ; GOEDE SCHUELER ; REGINA GORALCZYK</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_JP2014122215A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2014</creationdate><topic>FOODS OR FOODSTUFFS</topic><topic>FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BYSUBCLASSES A23B - A23J</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OFNUTRITIVE QUALITIES, PHYSICAL TREATMENT</topic><topic>THEIR TREATMENT, NOT COVERED BY OTHER CLASSES</topic><toplevel>online_resources</toplevel><creatorcontrib>FOWLER ANN</creatorcontrib><creatorcontrib>CLAUS KILPERT</creatorcontrib><creatorcontrib>GOEDE SCHUELER</creatorcontrib><creatorcontrib>REGINA GORALCZYK</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>FOWLER ANN</au><au>CLAUS KILPERT</au><au>GOEDE SCHUELER</au><au>REGINA GORALCZYK</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>NEW AGONIST FOR THERAPY OF DISORDER RELATED TO DAMAGED NEUROTRANSMISSION</title><date>2014-07-03</date><risdate>2014</risdate><abstract>PROBLEM TO BE SOLVED: To provide a nutritional supplementary food, a food and a livestock feed or a pharmaceutical composition, for therapy of disorders related to damaged neurotransmission in an animal including a human.SOLUTION: An oregano extract and a volatile component thereof are used. A nutritional supplementary food, a food and a livestock feed or a pharmaceutical composition contain such an extract or a volatile component thereof. The oregano extract is extracted from all or some of a plant belonging to Origanum such as origanum vulgare and Thymus such as thymus vulgaris. An extraction method is solvent, NO, supercritical COor steam distillation, or the like. The oregano extract is a serotonin reuptake inhibitor, a noradrenaline reuptake inhibitor and a dopamine reuptake inhibitor, and serves as an antidepressant drug, a mood improving agent, a stress emollient, a symptom improving agent, an anxiety reducing agent, an obsessional behavior reducing agent and the like. The administration target includes animals such as domestic animal and pet, fishes, and the like.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_JP2014122215A
source esp@cenet
subjects FOODS OR FOODSTUFFS
FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BYSUBCLASSES A23B - A23J
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OFNUTRITIVE QUALITIES, PHYSICAL TREATMENT
THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
title NEW AGONIST FOR THERAPY OF DISORDER RELATED TO DAMAGED NEUROTRANSMISSION
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T12%3A25%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=FOWLER%20ANN&rft.date=2014-07-03&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EJP2014122215A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true